Skip Navigation LinksHome > August 2007 - Volume 110 - Issue 2, Part 1 > First-Trimester Ultrasound Assessment of the Nasal Bone to S...

ACOG MEMBER SUBSCRIPTION ACCESS

If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.

Obstetrics & Gynecology:
doi: 10.1097/01.AOG.0000275281.19344.66
Current Commentary

First-Trimester Ultrasound Assessment of the Nasal Bone to Screen for Aneuploidy

Rosen, Todd MD1; D'Alton, Mary E. MD1; Platt, Lawrence D. MD2; Wapner, Ronald MD1; for the Maternal Fetal Medicine Foundation Nuchal Translucency Oversight Committee

Collapse Box

Abstract

Increasingly, women are choosing first-trimester risk assessment for Down syndrome and other aneuploid conditions. Recent studies have suggested that adding ultrasound assessment of the nasal bone to nuchal translucency thickness and maternal serum analytes in the first trimester will improve performance. This report assesses the current literature and discusses practical issues that must be addressed before widespread implementation of nasal bone screening in the United States.

© 2007 The American College of Obstetricians and Gynecologists

Login

ACOG MEMBER SUBSCRIPTION ACCESS

If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.

Article Tools

Share